Aduro Biotech
ADRO
#8332
Rank
NZ$0.39 B
Marketcap
NZ$24.36
Share price
4.18%
Change (1 day)
N/A
Change (1 year)

Revenue for Aduro Biotech (ADRO)

Revenue in 2020 (TTM): NZ$45.13 Million

According to Aduro Biotech's latest financial reports the company's current revenue is NZ$46.65 Million. In 2019 the company made a revenue of NZ$28.79 Million an increase over the revenue in the year 2018 that were of NZ$25.17 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aduro Biotech from 2014 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)NZ$45.13 M56.74%
2019NZ$28.79 M14.39%
2018NZ$25.17 M-12.48%
2017NZ$28.76 M-65.99%
2016NZ$84.57 M-30.55%
2015NZ$0.12 B445.07%
2014NZ$22.34 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sarepta Therapeutics
SRPT
NZ$4.02 B 8,533.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$1.18 B 2,432.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
NZ$0.13 B 198.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
NZ$1.6 M-96.56%๐Ÿ‡ฉ๐Ÿ‡ช Germany